NCT06509555View on ClinicalTrials.gov

Correlation Between Serum TK1 and Pathological Remission of Breast Cancer With Neoadjuvant Chemotherapy

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Breast NeoplasmsTK1

Interventions

OTHER

non-intervention

non-intervention

Trial Locations (1)

Unknown

RECRUITING

Yunnan Cancer Hospital, Kunming

All Listed Sponsors

lead

Yunnan Cancer Hospital

OTHER